Percutaneous Renal Sympathetic Denervation for the Treatment of Resistant Hypertension with Heart Failure: First Experience in Korea.
10.3346/jkms.2013.28.6.951
- Author:
Jeong Hoon YANG
1
;
Seung Hyuk CHOI
;
Hyeon Cheol GWON
Author Information
1. Division of Cardiology, Department of Medicine, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. sh1214.choi@samsung.com
- Publication Type:Case Reports
- Keywords:
Resistant Hypertension;
Renal Sympathetic Denervation
- MeSH:
Adult;
Blood Pressure;
Blood Pressure Monitoring, Ambulatory;
Heart Failure/complications;
Humans;
Hypertension/complications/*surgery;
Kidney/ultrasonography;
Male;
Renal Artery/radiography;
Republic of Korea;
Sympathectomy
- From:Journal of Korean Medical Science
2013;28(6):951-954
- CountryRepublic of Korea
- Language:English
-
Abstract:
Percutaneous catheter-based therapy has recently been introduced to decrease blood pressure by ablation of efferent and afferent sympathetic renal nerves. The patient described here had a seven-year history of hypertension and presented with poorly controlled blood pressure despite antihypertensive therapy with four different drugs. A 44-yr-old man underwent percutaneous renal denervation under local anesthesia using an ablation catheter. After six months of follow-up his blood pressure had dropped 49/37 mmHg with a decrease in 24-hr ambulatory BP of 20/18 mmHg. Renal Doppler ultrasound showed no significant stenosis in either renal artery. This is the first case of successful percutaneous renal denervation, which has recently become available in Korea.
